Evaluating the use of creatine in kidney function

Evaluating the use of creatine as a sport supplement in renal eGFR by measuring serum creatinine and cystatine-C

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

IRCT

Registry ID

IRCT20250427065486N1

Enrollment

Registered

2025-12-05

Start date

2025-12-22

Completion date

Unknown

Last updated

2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic kidney disease. Chronic kidney disease (CKD)

Interventions

Intervention 1: Intervention group: Creatine Monohydrate. Intervention 2: Control group: Without taking creatine monohydrate.

Eligibility

Sex/Gender

Male

Age

18 Years to 30 Years

Inclusion criteria

Inclusion criteria: Regular exercise at least 3 one hour session a week

Exclusion criteria

Exclusion criteria: Any past medical history (CKD and etc.)

Design outcomes

Primary

Measure	Time frame
EGFR-Cr. Timepoint: Three months later. Method of measurement: Blood creatinine test.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMostafa Rezaei

Esfahan University of Medical Sciences

mostafa.rezai.1584@gmail.com+98 31 3620 2020

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026